Gen İlaç Requested An IPO

Gen İlaç requested an IPO. The company applied to the CMB for the public offering.

Recently, a new one was added to the rapidly increasing public offering transactions. Finally, the drug manufacturer Gen İlaç applied for the public offering. In the written statement made by Gen İlaç, it was announced that the openness rate in the public offering was determined as 20.83 percent. Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. applied to the Capital Markets Board (CMB) for the approval of the public offering prospectus. According to the written statement made by the company, the free float rate of the public offering to be held under the leadership of Oyak Yatırım was determined as 20.83 percent. It was stated that this ratio would increase to 22.92 percent in case of using the right of additional sale, and it was said that the methods of capital increase and joint sales would be used together in the public offering. It was noted that in the public offering transaction, which is planned to be made with the method of collecting demand with a fixed price, the pre-emptive rights of all existing partners are restricted and the nominal value of the shares to be offered to the public by the paid capital increase method will be 50 million TL and this amount constitutes approximately 80 percent of the total public offering. The nominal value of Gen İlaç's shares to be offered to the public within the scope of its current shareholding sale is 12.5 million TL, and the total nominal value of the publicly offered shares is 62.5 million TL. It was stated that in case of excess demand, it is planned to add 6.3 million TL nominal value shares to the amount of shares to be offered to the public within the scope of joint sales. In case of additional sales, shares with a total nominal value of 68.8 million TL will be offered to the public. In the statement made by the company, it was stated that Gen İlaç, which has been operating for 23 years, has been operating in Ankara, Istanbul, Izmir, Trabzon, Azerbaijan, Kazakhstan, Russia, Germany and Uzbekistan.